The Epidemiology of HIV-1 Transmitted Drug Resistance

The human immunodeficiency virus (HIV) was first discovered in 1983. In 2009, it was estimated that 33.3 (31.4 -35.3) million individuals are infected with HIV worldwide. In that year 1.8 (1.6-2.1) million people died from HIV. Although the virus continues to spread, the number of new infections has fallen from an estimated 3.2 (3.0 -3.5) million in 1997 to 2.6 (2.3 – 2.8) million in 2009. There are several explanations for this decrease. First, the use of antiretrovirals has slowed down the epidemic by suppressing viral replication and thereby the HIV RNA load [2]. This RNA load is a key factor in determining transmissibility of HIV. Second, sexual risk behaviour has decreased in most countries. Third, HIV prevalence follows an ‘S’ curve, like any infectious disease where it start slowly and gradually. In the final phase of the epidemic, people are either no longer infectious (due to effective treatment) or deaths outnumber new cases, so that the total number alive and infected passes its peak and begin to decline or reach a plateau. The majority of new HIV infections continue to occur in sub-Saharan Africa. Here, an estimated 1.8 (1.6 -2.0) million people were newly infected in 2009 and 22.5 million (20.9 -24.2) people were living with HIV in this region (figure 1). In Europe, the HIV-1 epidemic is much smaller, with an estimated 130,000 (110,000-160,000) newly infected in Western and Central Europe in 2009. This results in 820,000 (720,000-910,000) individuals living with HIV-1 and a prevalence of 0.2% in this region

Überblick über die neueren Arbeiten auf dem Gebiet des Wasserstoff-und Tritiumverhaltens in Hochtemperaturreaktoren

This report comprises the contributions of members of the "Institut für Reaktor-Entwicklung" (IRE) to the "Und Seminar on Hydrogen and Tritium Behaviour in High Temperature Reactors", which was held March 8, 1978, at KFA Jülich. At the beginning the problem is introduced and the investigations at IRE related to this area are presented in their context. Then follow the individual papers on the subjects mentioned. At first the experiences with the operation of the experimental facility AUWARM and the newest results in the current testing program are discussed. Therafter the model investigations with hydrogen and deuterium on the problem of hydrogen- and tritium permeation are reported and a computer program for balancing tritium in pebble-bed-HTRs is described. Last notleast the studies on the behaviour of tritium in matrix graphite and the experiments on primary coolant purification by titanium gettering are shortly communicated. The results given in this report are preliminary informations on the actual status of the current investigations

Effects of Interventions on Cerebral Perfusion in the Alzheimer's Disease Spectrum:A Systematic Review

Cerebral perfusion dysfunctions are seen in the early stages of Alzheimer’s disease (AD). We systematically reviewed the literature to investigate the effect of pharmacological and non-pharmacological interventions on cerebral hemodynamics in randomized controlled trials involving AD patients or Mild Cognitive Impairment (MCI) due to AD. Studies involving other dementia types were excluded. Data was searched in April 2021 on MEDLINE, Embase, and Web of Science. Risk of bias was assessed using Cochrane Risk of Bias Tool. A metasynthesis was performed separating results from MCI and AD studies. 31 studies were included and involved 310 MCI and 792 CE patients. The MCI studies (n = 8) included physical, cognitive, dietary, and pharmacological interventions. The AD studies (n = 23) included pharmacological, physical interventions, and phytotherapy. Cerebral perfusion was assessed with PET, ASL, Doppler, fNIRS, DSC-MRI, Xe-CT, and SPECT. Randomization and allocation concealment methods and subject characteristics such as AD-onset, education, and ethnicity were missing in several papers. Positive effects on hemodynamics were seen in 75 % of the MCI studies, and 52 % of the AD studies. Inserting cerebral perfusion outcome measures, together with established AD biomarkers, is fundamental to target all disease mechanisms and understand the role of cerebral perfusion in AD

Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case–control study

In North Jutland County, Denmark, we investigated whether use of oral glucocorticoids was associated with an increased risk of developing basal cell carcinoma (BCC), squamous cell carcinoma (SCC), malignant melanoma (MM), and non-Hodgkin's lymphoma (NHL). From the Danish Cancer Registry we identified 5422 BCC, 935 SCC, 983 MM, and 481 NHL cases during 1989–2003. Using risk-set sampling we selected four age- and gender-matched population controls for each case from the Civil Registration System. Prescriptions for oral glucocorticoids before diagnosis were obtained from the Prescription Database of North Jutland County on the basis of National Health Service data. We used conditional logistic regression to estimate incidence rate ratios (IRRs), adjusting for chronic medical diseases (information about these were obtained from the National Patient Registry) and use of other immunosuppressants. We found slightly elevated risk estimates for BCC (IRR, 1.15 (95% CI: 1.07–1.25)), SCC (IRR, 1.14 (95% CI: 0.94–1.39)), MM (IRR, 1.15 (95% CI: 0.94–1.41), and NHL (IRR, 1.11 (95% CI: 0.85–1.46)) among users of oral glucocorticoids. Our study supports an overall association between glucocorticoid use and risk of BCC that cannot be explained by the presence of chronic diseases or concomitant use of other immunosuppressants

Recent Nuclear Astrophysics Measurements using the TwinSol Separator

Many astrophysical events, such as novae and X-ray bursts, are powered by reactions with radioactive nuclei. Studying the properties of these nuclei in the laboratory can therefore further our understanding of these astrophysical explosions. The TwinSol separator at the University of Notre Dame has recently been used to produce intense (∼106 pps) beams of 17F. In this article, some of the first measurements with these beams are discussed

Determining the \u3csup\u3e14\u3c/sup\u3eO(α,p)\u3csup\u3e17\u3c/sup\u3eF astrophysical rate from Measurements at TwinSol

The 14O(α,p)17F reaction is an important trigger reaction to the α-p process in X-ray bursts. The most stringent experimental constraints on its astrophysical rate come from measurements of the time-inverse reaction, 17F(p,α)14O. Previous studies of this inverse reaction have sufficiently characterized the high-energy dependence of the cross section but there are still significant uncertainties at lower energies. A new measurement of the 17F(p,α)14O cross section is underway at the Twin Solenoid (TwinSol) facility at the University of Notre Dame using an in-flight secondary 17F beam. The initial results are promising but improvements are needed to complete the measurement. The initial data and plans for an improved measurement are presented in this manuscript